Crinetics Pharmaceuticals (CRNX) ARS2023 FY Annual report to shareholders
Filed: 25 Apr 24, 4:50pm
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.